CLSI M24-A2

Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard, M24A2E

Clinical and Laboratory Standards Institute, 03/01/2011

Publisher: CLSI

File Format: PDF

$90.00$180.00

Description

Published:01/03/2011

Pages:76

File Size:1 file , 1.7 MB

Note:This product is unavailable in Russia, Belarus

This standard provides protocols and related quality control parameters and interpretive criteria for the susceptibility testing of mycobacteria, Nocardiae spp. and other aerobic actinomycetes.

More CLSI standard pdf

CLSI C52-A2

Toxicology and Drug Testing in the Clinical Laboratory; Approved Guideline, Second Edition, C52A2E

$143.00 $287.20

CLSI H43-A2 (R2018)

Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline, Second Edition, A43-A2

$90.00 $180.00

CLSI M48P

Laboratory Detection and Identification of Mycobacteria; Proposed Guideline, M48-P

$132.00 $265.48

CLSI QMS04-A2

Laboratory Design; Approved Guideline - Second Edition, QMS04A2E

$140.00 $281.60